CITIUS PHARMAC (Germany) Price on October 22, 2024
47N Stock | EUR 3.29 0.00 0.00% |
If you're considering investing in CITIUS Stock, it is important to understand the factors that can impact its price. As of today, the current price of CITIUS PHARMAC stands at 3.29, as last reported on the 15th of December 2024, with the highest price reaching 3.29 and the lowest price hitting 3.29 during the day. CITIUS PHARMAC DL secures Sharpe Ratio (or Efficiency) of -0.2, which signifies that the company had a -0.2% return per unit of volatility over the last 3 months. CITIUS PHARMAC DL exposes eighteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm CITIUS PHARMAC's mean deviation of 4.81, and Risk Adjusted Performance of (0.14) to double-check the risk estimate we provide.
CITIUS Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
CITIUS |
Sharpe Ratio = -0.1957
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | 47N |
Estimated Market Risk
7.83 actual daily | 69 69% of assets are less volatile |
Expected Return
-1.53 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.2 actual daily | 0 Most of other assets perform better |
Based on monthly moving average CITIUS PHARMAC is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CITIUS PHARMAC by adding CITIUS PHARMAC to a well-diversified portfolio.
CITIUS PHARMAC Valuation on October 22, 2024
It is possible to determine the worth of CITIUS PHARMAC on a given historical date. On October 22, 2024 CITIUS was worth 7.79 at the beginning of the trading date compared to the closed value of 7.8. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of CITIUS PHARMAC stock. Still, in general, we apply an absolute valuation method to find CITIUS PHARMAC's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of CITIUS PHARMAC where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against CITIUS PHARMAC's related companies.
Open | High | Low | Close | Volume | |
7.99 | 7.99 | 7.99 | 7.99 | 1.00 | |
10/22/2024 | 7.79 | 7.87 | 7.79 | 7.80 | 1.00 |
7.65 | 7.73 | 7.65 | 7.65 | 1.00 |
Backtest CITIUS PHARMAC | | | CITIUS PHARMAC History | | | CITIUS PHARMAC Valuation | Previous | Next |
CITIUS PHARMAC Trading Date Momentum on October 22, 2024
On October 23 2024 CITIUS PHARMAC DL was traded for 7.65 at the closing time. The highest daily price throughout the period was 7.73 and the lowest price was 7.65 . There was no trading activity during the period 1.0. Lack of trading volume on 10/23/2024 added to the next day price reduction. The daily price change to closing price of the next trading day was 1.92% . The overall trading delta to current closing price is 4.62% . |
CITIUS PHARMAC DL Fundamentals Correlations and Trends
By evaluating CITIUS PHARMAC's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among CITIUS PHARMAC's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. CITIUS financial account trend analysis is a perfect complement when working with valuation or volatility modules.About CITIUS PHARMAC Stock history
CITIUS PHARMAC investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CITIUS is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CITIUS PHARMAC DL will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CITIUS PHARMAC stock prices may prove useful in developing a viable investing in CITIUS PHARMAC
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products targeting medical needs with a focus on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey. CITIUS PHARMAC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 10 people.
CITIUS PHARMAC Stock Technical Analysis
CITIUS PHARMAC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
CITIUS PHARMAC Period Price Range
Low | December 15, 2024
| High |
0.00 | 0.00 |
CITIUS PHARMAC DL cannot be verified against its exchange. Please verify the symbol is currently traded on Frankfurt Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
CITIUS PHARMAC December 15, 2024 Market Strength
Market strength indicators help investors to evaluate how CITIUS PHARMAC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CITIUS PHARMAC shares will generate the highest return on investment. By undertsting and applying CITIUS PHARMAC stock market strength indicators, traders can identify CITIUS PHARMAC DL entry and exit signals to maximize returns
CITIUS PHARMAC Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for CITIUS PHARMAC's price direction in advance. Along with the technical and fundamental analysis of CITIUS Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CITIUS to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.14) | |||
Jensen Alpha | (1.57) | |||
Total Risk Alpha | (2.53) | |||
Treynor Ratio | (22.99) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for CITIUS Stock analysis
When running CITIUS PHARMAC's price analysis, check to measure CITIUS PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CITIUS PHARMAC is operating at the current time. Most of CITIUS PHARMAC's value examination focuses on studying past and present price action to predict the probability of CITIUS PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CITIUS PHARMAC's price. Additionally, you may evaluate how the addition of CITIUS PHARMAC to your portfolios can decrease your overall portfolio volatility.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |